サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1508473

分子オンコロジー市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

Molecular Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 145 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
分子オンコロジー市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測
出版日: 2024年05月07日
発行: Transparency Market Research
ページ情報: 英文 145 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

分子オンコロジー市場- 調査範囲

TMRの調査レポート「分子オンコロジーの世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の分子オンコロジー市場の収益と予測を提供しています。また、2024年から2034年までの世界の分子オンコロジー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、分子オンコロジー市場を理解しました。

市場スナップショット
2023年の市場規模 23億米ドル
2034年の市場規模 74億米ドル
CAGR 11%

当レポートでは、世界の分子オンコロジー市場の競合情勢について調査しています。世界の分子オンコロジー市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の分子オンコロジー市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場分析と予測, 2020-2034年

第5章 主要洞察

  • 主要M&A
  • 地域別/世界規模の規制シナリオ
  • がんの罹患率
  • COVID-19の影響分析

第6章 世界市場分析と予測：製品別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：製品別, 2020-2034年
    • 機器
    • 試薬
    • その他
  • 製品別の市場の魅力

第7章 世界市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：用途別, 2020-2034年
    • 肺がん
    • 乳がん
    • 大腸がん
    • 卵巣がん
    • 膵臓がん
    • その他
  • 用途別の市場の魅力

第8章 世界市場分析と予測：技術別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：技術別, 2020-2034年
    • PCR（rt-PCR、d-PCR）
    • NGS（次世代シーケンシング）
    • マイクロアレイ
    • FISH（蛍光in situハイブリダイゼーション）
    • その他
  • 技術別の市場の魅力

第9章 世界市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/ 進展
  • 市場金額予測：エンドユーザー別, 2020-2034年
    • 病院と診療所
    • 診断検査室
    • がんセンターと専門クリニック
    • その他（政府および公衆衛生機関）
  • エンドユーザー別の市場の魅力

第10章 世界市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第11章 北米の市場分析と予測

  • 米国
  • カナダ

第12章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域

第13章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第14章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第15章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第16章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Qiagen N.V.
    • Agilent Technologies, Inc.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Roche Diagnostics
    • Genomic Health, Inc.
    • Myriad Genetics, Inc.
図表

List of Tables

  • Table 01: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 02: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 03: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 04: Global Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 05: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 08: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 09: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 10: North America Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 13: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 14: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 15: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 18: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 19: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 20: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 23: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 24: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 25: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 28: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 29: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 30: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Molecular Oncology Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 03: Global Molecular Oncology Market Share Analysis, by Product, 2023
  • Figure 04: Global Molecular Oncology Market Share Analysis, by Product, 2034
  • Figure 05: Global Molecular Oncology Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 06: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 07: Global Molecular Oncology Market Share Analysis, by Cancer Type, 2023
  • Figure 08: Global Molecular Oncology Market Share Analysis, by Cancer Type, 2034
  • Figure 09: Global Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 10: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 11: Global Molecular Oncology Market Share Analysis, by Technology, 2023
  • Figure 12: Global Molecular Oncology Market Share Analysis, by Technology, 2034
  • Figure 13: Global Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 14: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Molecular Oncology Market Share Analysis, by End-user, 2023
  • Figure 16: Global Molecular Oncology Market Share Analysis, by End-user, 2034
  • Figure 17: Global Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 18: Global Molecular Oncology Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 19: Global Molecular Oncology Market Share Analysis, by Region, 2023
  • Figure 20: Global Molecular Oncology Market Share Analysis, by Region, 2034
  • Figure 21: Global Molecular Oncology Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 22: North America Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 23: North America Molecular Oncology Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 24: North America Molecular Oncology Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 25: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 26: North America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 27: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 28: North America Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 29: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 30: North America Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 31: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 32: North America Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 34: Europe Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 35: Europe Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 36: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 37: North America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 38: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 39: Europe Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 40: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 41: Europe Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 42: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 43: Europe Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 45: Asia Pacific Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 46: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 48: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 49: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 50: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 51: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 52: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 53: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 54: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 55: Latin America Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 56: Latin America Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Latin America Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 58: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 59: Latin America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 60: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 61: Latin America Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 62: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 63: Latin America Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 64: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Latin America Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 67: Middle East & Africa Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 70: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 71: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 72: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 73: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 74: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 75: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 76: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL86057

Molecular Oncology Market - Scope of Report

TMR's report on the global molecular oncology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global molecular oncology market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global molecular oncology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the molecular oncology market.

Market Snapshot
Market Value in 2023US$ 2.3 Bn
Market Value in 2034US$ 7.4 Bn
CAGR11%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global molecular oncology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global molecular oncology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global molecular oncology market.

The report delves into the competitive landscape of the global molecular oncology market. Key players operating in the global molecular oncology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global molecular oncology market profiled in this report.

Key Questions Answered in Global molecular oncology Market Report:

  • What is the sales/revenue generated by molecular oncology across all regions during the forecast period?
  • What are the opportunities in the global molecular oncology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Molecular Oncology Market - Research Objectives and Research Approach

The comprehensive report on the global molecular oncology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global molecular oncology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global molecular oncology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Molecular Oncology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Molecular Oncology Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Regulatory Scenario by Region/Globally
  • 5.3. Prevalence of Cancer
  • 5.4. COVID-19 Impact Analysis

6. Global Molecular Oncology Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2020-2034
    • 6.3.1. Instruments
    • 6.3.2. Reagents
    • 6.3.3. Others
  • 6.4. Market Attractiveness By Product

7. Global Molecular Oncology Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Lung Cancer
    • 7.3.2. Breast Cancer
    • 7.3.3. Colorectal Cancer
    • 7.3.4. Ovarian Cancer
    • 7.3.5. Pancreatic Cancer
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Molecular Oncology Market Analysis and Forecasts, By Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Technology, 2020-2034
    • 8.3.1. PCR (rt-PCR, d-PCR)
    • 8.3.2. NGS (Next Generation Sequencing)
    • 8.3.3. Microarray
    • 8.3.4. FISH (Fluorescent in situ-hybridization)
    • 8.3.5. Others
  • 8.4. Market Attractiveness By Technology

9. Global Molecular Oncology Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Hospitals and Clinics
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Cancer Centers and Specialty Clinics
    • 9.3.4. Others (Government and Public Health Agencies)
  • 9.4. Market Attractiveness By End-user

10. Global Molecular Oncology Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Molecular Oncology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2020-2034
    • 11.2.1. Instruments
    • 11.2.2. Reagents
    • 11.2.3. Others
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Lung Cancer
    • 11.3.2. Breast Cancer
    • 11.3.3. Colorectal Cancer
    • 11.3.4. Ovarian Cancer
    • 11.3.5. Pancreatic Cancer
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Technology, 2020-2034
    • 11.4.1. PCR (rt-PCR, d-PCR)
    • 11.4.2. NGS (Next Generation Sequencing)
    • 11.4.3. Microarray
    • 11.4.4. FISH (Fluorescent in situ-hybridization)
    • 11.4.5. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Cancer Centers and Specialty Clinics
    • 11.5.4. Others (Government and Public Health Agencies)
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Application
    • 11.7.3. By Technology
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Molecular Oncology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2020-2034
    • 12.2.1. Instruments
    • 12.2.2. Reagents
    • 12.2.3. Others
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Lung Cancer
    • 12.3.2. Breast Cancer
    • 12.3.3. Colorectal Cancer
    • 12.3.4. Ovarian Cancer
    • 12.3.5. Pancreatic Cancer
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Technology, 2020-2034
    • 12.4.1. PCR (rt-PCR, d-PCR)
    • 12.4.2. NGS (Next Generation Sequencing)
    • 12.4.3. Microarray
    • 12.4.4. FISH (Fluorescent in situ-hybridization)
    • 12.4.5. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Diagnostic Laboratories
    • 12.5.3. Cancer Centers and Specialty Clinics
    • 12.5.4. Others (Government and Public Health Agencies)
  • 12.6. Market Value Forecast By Country, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Application
    • 12.7.3. By Technology
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Molecular Oncology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product, 2020-2034
    • 13.2.1. Instruments
    • 13.2.2. Reagents
    • 13.2.3. Others
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Lung Cancer
    • 13.3.2. Breast Cancer
    • 13.3.3. Colorectal Cancer
    • 13.3.4. Ovarian Cancer
    • 13.3.5. Pancreatic Cancer
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Technology, 2020-2034
    • 13.4.1. PCR (rt-PCR, d-PCR)
    • 13.4.2. NGS (Next Generation Sequencing)
    • 13.4.3. Microarray
    • 13.4.4. FISH (Fluorescent in situ-hybridization)
    • 13.4.5. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Diagnostic Laboratories
    • 13.5.3. Cancer Centers and Specialty Clinics
    • 13.5.4. Others (Government and Public Health Agencies)
  • 13.6. Market Value Forecast By Country, 2020-2034
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Application
    • 13.7.3. By Technology
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Molecular Oncology Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product, 2020-2034
    • 14.2.1. Instruments
    • 14.2.2. Reagents
    • 14.2.3. Others
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Lung Cancer
    • 14.3.2. Breast Cancer
    • 14.3.3. Colorectal Cancer
    • 14.3.4. Ovarian Cancer
    • 14.3.5. Pancreatic Cancer
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Technology, 2020-2034
    • 14.4.1. PCR (rt-PCR, d-PCR)
    • 14.4.2. NGS (Next Generation Sequencing)
    • 14.4.3. Microarray
    • 14.4.4. FISH (Fluorescent in situ-hybridization)
    • 14.4.5. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Diagnostic Laboratories
    • 14.5.3. Cancer Centers and Specialty Clinics
    • 14.5.4. Others (Government and Public Health Agencies)
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Application
    • 14.7.3. By Technology
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Molecular Oncology Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product, 2020-2034
    • 15.2.1. Instruments
    • 15.2.2. Reagents
    • 15.2.3. Others
  • 15.3. Market Value Forecast By Application, 2020-2034
    • 15.3.1. Lung Cancer
    • 15.3.2. Breast Cancer
    • 15.3.3. Colorectal Cancer
    • 15.3.4. Ovarian Cancer
    • 15.3.5. Pancreatic Cancer
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Technology, 2020-2034
    • 15.4.1. PCR (rt-PCR, d-PCR)
    • 15.4.2. NGS (Next Generation Sequencing)
    • 15.4.3. Microarray
    • 15.4.4. FISH (Fluorescent in situ-hybridization)
    • 15.4.5. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Hospitals and Clinics
    • 15.5.2. Diagnostic Laboratories
    • 15.5.3. Cancer Centers and Specialty Clinics
    • 15.5.4. Others (Government and Public Health Agencies)
  • 15.6. Market Value Forecast By Country, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Application
    • 15.7.3. By Technology
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Thermo Fisher Scientific Inc.
      • 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.1.2. Product Portfolio
      • 16.2.1.3. Financial Overview
      • 16.2.1.4. SWOT Analysis
      • 16.2.1.5. Strategic Overview
    • 16.2.2. Illumina, Inc.
      • 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.2.2. Product Portfolio
      • 16.2.2.3. Financial Overview
      • 16.2.2.4. SWOT Analysis
      • 16.2.2.5. Strategic Overview
    • 16.2.3. Qiagen N.V.
      • 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.3.2. Product Portfolio
      • 16.2.3.3. Financial Overview
      • 16.2.3.4. SWOT Analysis
      • 16.2.3.5. Strategic Overview
    • 16.2.4. Agilent Technologies, Inc.
      • 16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.4.2. Product Portfolio
      • 16.2.4.3. Financial Overview
      • 16.2.4.4. SWOT Analysis
      • 16.2.4.5. Strategic Overview
    • 16.2.5. Abbott Laboratories
      • 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.5.2. Product Portfolio
      • 16.2.5.3. Financial Overview
      • 16.2.5.4. SWOT Analysis
      • 16.2.5.5. Strategic Overview
    • 16.2.6. Bio-Rad Laboratories, Inc.
      • 16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.6.2. Product Portfolio
      • 16.2.6.3. Financial Overview
      • 16.2.6.4. SWOT Analysis
      • 16.2.6.5. Strategic Overview
    • 16.2.7. Roche Diagnostics
      • 16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.7.2. Product Portfolio
      • 16.2.7.3. Financial Overview
      • 16.2.7.4. SWOT Analysis
      • 16.2.7.5. Strategic Overview
    • 16.2.8. Genomic Health, Inc.
      • 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.8.2. Product Portfolio
      • 16.2.8.3. Financial Overview
      • 16.2.8.4. SWOT Analysis
      • 16.2.8.5. Strategic Overview
    • 16.2.9. Myriad Genetics, Inc.
      • 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.9.2. Product Portfolio
      • 16.2.9.3. Financial Overview
      • 16.2.9.4. SWOT Analysis
      • 16.2.9.5. Strategic Overview